Agostino
Migone de Amicis

Of Counsel
The quantities compete for space, the qualities complement each other. Dietrich Bonhöffer

Agostino predominantly deals with regulatory matters in the areas of pharmaceuticals, medical devices and nutraceutics and extends these important areas connected to clinical research.

Throughout his long and valuable experience, gathered through continuing assistance to manufacturing companies and acting as a consultant or member of institutions (e.g., Independent Ethics Committees, research centers, public and private foundations), he specifically handled matters concerning development of new products from their design to industrialization, clinical trials for registration, marketing authorization, obtaining prices and reimbursement, participation in public procedures for the awarding of supplies to the National Health Service, distribution and promotion/scientific information, continuing training of healthcare professionals (CCE), pharmacovigilance, clinical trials and observational studies aimed at obtaining additional indications (for profit as well as non-profit purposes). He had also handled all compliance issues of the Life Sciences sector (such as personal data protection, prevention of corrupt practices, behavioral models and vigilance according to Decree 231/2001), as well as extraordinary and joint venture transactions, and the related civil, criminal and administrative judicial procedures.

Beside specialist activities, he has always assisted clients in various fields of civil, commercial, corporate and EU law, particularly in environmental, public and private tenders, agri-food and biotechnologies, and generally with respect to activities governed by special regulations.

In 2011, he was awarded the TopLegal “Professional of the Year – Life Science” prize and has been constantly ranked in the last years in international directories such as Chambers, the Legal 500 and Who’s Who Legal.

From 1975 to 2020 Agostino was a member of the Law Firm Pavia e Ansaldo, being a partner from 1986 to 2016, and of counsel from 2017 to 2020, and heading the Life Sciences – Regulatory Department. His joining LCA since 2021, together with younger valuable professionals, further strengthens and consolidates the experience and goodwill of the Firm, which is already significant in this important sector, and offers to clients an increasingly qualified and efficient service in the many articulations of the healthcare/pharmaceutical world.

In the past, he was an assistant professor of the 1st Chair of International Law at the Law Faculty of the University of Milan. From 2008 to 2014, he held seminars of French legal language at the University of Milan and of Administrative Law at the Catholic University of Milan.

  • Legal 500 2024

    Leading Individual for Healthcare and Life Sciences

  • Chambers Europe 2024

    Ranked Lawyer for Life Sciences

Commercial and corporate Litigation, Arbitration and ADR Life Sciences Manufacturing

You might also be interested in

29.03.2024
The Legal 500 (EMEA) – LCA Studio Legale

New Legal 500 rankings released. LCA confirms the positive trend with many new achievements in both practice/industry a ...

15.03.2024
Chambers Europe & Global 2024 – LCA Studio Legale

LCA and its professionals are receiving increasing recognition in the Chambers and Partners rankings

13.04.2022
The Legal 500 confirms LCA’s presence in the rankings

Another great achievement for LCA Studio Legale and its professionals!